ALIBABA HEALTH INFORMATION TECHNOLOGY LIMITED |
Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
| 3.11 HKD | +5.42% |
|
+16.92% | -26.65% |
| 03/04 | Alibaba Health Refutes Rumors of Purchase of Telemedicine Platform HaoDF | MT |
| 28/03 | Alibaba Health Information Technology Limited and Alibaba.com Enter Shared Services Agreement | CI |
| Sales 2024 * | 28.51B 3.93B 30.79B 328B | Sales 2025 * | 33.31B 4.6B 35.99B 383B | Capitalization | 43.91B 6.06B 47.44B 505B |
|---|---|---|---|---|---|
| Net income 2024 * | 766M 106M 827M 8.81B | Net income 2025 * | 1.14B 157M 1.23B 13.1B | EV / Sales 2024 * | 1.17 x |
| Net cash position 2024 * | 10.7B 1.48B 11.56B 123B | Net cash position 2025 * | 11.99B 1.66B 12.95B 138B | EV / Sales 2025 * | 0.96 x |
| P/E ratio 2024 * |
51.4
x | P/E ratio 2025 * |
34
x | Employees | 1,547 |
| Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 37.22% |
More Fundamentals
* Assessed data
More news
More recommendations
More press releases
More news
| 1 day | +5.42% | ||
| 1 week | +16.92% | ||
| Current month | -2.20% | ||
| 1 month | +1.30% | ||
| 3 months | -0.64% | ||
| 6 months | -33.40% | ||
| Current year | -26.65% |
1 week
2.63
3.13
1 month
2.593.31
Current year
2.594.30
1 year
2.595.82
3 years
2.5924.40
5 years
2.5930.15
10 years
2.5930.15
| Managers | Title | Age | Since |
|---|---|---|---|
Di Fan Shen
CEO | Chief Executive Officer | 46 | - |
Yan Wu Tu
DFI | Director of Finance/CFO | 46 | 01/19/01 |
Shun Yan Zhu
CHM | Chairman | 53 | 16/20/16 |
| Members of the board | Title | Age | Since |
|---|---|---|---|
Yi Hong Wu
BRD | Director/Board Member | 56 | 11/23/11 |
Shun Yan Zhu
CHM | Chairman | 53 | 16/20/16 |
Rong Shao
BRD | Director/Board Member | 62 | 11/23/11 |
| Name | Weight | AuM | 1st Jan change | Investor Rating |
|---|---|---|---|---|
| 2.59% | 274 M€ | +7.18% | - | |
| 1.56% | 78 M€ | +11.64% | - | |
| 1.56% | 11 M€ | +9.73% | - | |
| 1.42% | 0 M€ | 0.00% | - |
| Date | Price | Change | Volume |
|---|---|---|---|
| 29/24/29 | 3.11 | +5.42% | 38 504 000 |
| 26/24/26 | 2.95 | +7.27% | 73,431,710 |
| 25/24/25 | 2.75 | 0.00% | 37,589,470 |
| 24/24/24 | 2.75 | +2.23% | 42,049,670 |
| 23/24/23 | 2.69 | +1.13% | 29,036,440 |
Delayed Quote Hong Kong S.E., April 29, 2024 at 08:54 am IST
More quotes
Alibaba Health Information Technology Limited is specialized in the direct sale of pharmaceuticals. The turnover is divided across the following activities:
- direct sale of pharmaceuticals (85.2%);
- online sale of pharmaceuticals(12.7%);
- direct healthcare services (1.8%);
- online healthcare services and monitoring of pharmaceuticals (0.3%).
The turnover is divided into the revenue sources of product sales (80.8%) and services (19.2%).
The geographical breakdown of the turnover is as follows: mainland China (95.8%) and Hong Kong (4.2%).
Sector
Drug Retailers
Calendar
23/05/2024
- Q4 2024 Earnings Release (Projected)
Related indices
Trading Rating
Investor Rating
ESG Refinitiv
B
Sell
Buy
Mean consensus
BUY
Number of Analysts
20
Last Close Price
2.731
CNY
Average target price
5.072
CNY
Spread / Average Target
+85.72%
EPS Revisions
| 1st Jan change | Capi. | |
|---|---|---|
| -26.65% | 6.06B | |
| -32.21% | 15.27B | |
| -28.26% | 10.84B | |
| +8.14% | 6.04B | |
| -11.41% | 5.86B | |
| -1.17% | 4.71B | |
| +52.19% | 4.29B | |
| -14.86% | 3.33B | |
| -6.93% | 3.01B | |
| -1.22% | 2.8B |
- Stock Market
- Equities
- 241 Stock
